$1.2B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | SRRK Scholar Rock Hldg Corp | 6.9M | +0.0% | $379M | 31.2% |
| 2 | ALMS Alumis Inc | 6.3M | +0.0% | $179M | 14.7% |
| 3 | MLYS Mineralys Therapeutics Inc | 5.9M | +0.0% | $158M | 13.0% |
| 4 | SEPN Septerna Inc | 3.1M | +0.0% | $105M | 8.7% |
| 5 | ALMR Alamar Biosciences Inc | 2.5M | — | $67M | 5.5% |
| 6 | NGNE Neurogene Inc | 1.7M | +0.0% | $54M | 4.4% |
| 7 | KLRS Kalaris Therapeutics Inc | 12.9M | −0.5% | $52M | 4.3% |
| 8 | SGP Spyglass Pharma Inc | 2.1M | +0.0% | $47M | 3.9% |
| 9 | STRO Sutro Biopharma Inc | 1.1M | +0.0% | $35M | 2.9% |
| 10 | IVA Inventiva Sa | 6.3M | +21.6% | $24M | 2.0% |
| 11 | JBIO Jade Biosciences Inc | 736,237 | −24.0% | $16M | 1.3% |
| 12 | PBLS Parabilis Medicines Inc | 556,044 | — | $15M | 1.3% |
| 13 | VTVT Vtv Therapeutics Inc | 298,496 | +0.0% | $11M | 0.9% |
| 14 | AQST Aquestive Therapeutics Inc | 2.5M | +0.0% | $10M | 0.9% |
| 15 | NKTX Nkarta Inc | 3.5M | +0.0% | $10M | 0.8% |
| 16 | ARTV Artiva Biotherapeutics Inc | 954,861 | — | $9M | 0.8% |
| 17 | RANI Rani Therapeutics Hldgs Inc | 10.4M | +22.0% | $8M | 0.6% |
| 18 | AGMB Agomab Therapeutics Nv | 600,000 | +0.0% | $8M | 0.6% |
| 19 | ABIVAX SA Abivax Sa | 55,095 | −2.6% | $7M | 0.6% |
| 20 | XFOR X4 Pharmaceuticals Inc | 1.4M | −23.8% | $7M | 0.5% |
| 21 | ELOX Eloxx Pharmaceuticals Inc | 400,000 | — | $6M | 0.5% |
| 22 | CHRS Coherus Oncology Inc | 3.4M | +0.0% | $5M | 0.4% |
| 23 | UPB Upstream Bio Inc | 353,717 | −51.9% | $2M | 0.2% |
| 24 | GOSS Gossamer Bio Inc | 7.2M | +0.0% | $1M | 0.1% |